American Biomanufacturing Summit


Lunch & Learn

Roundtables


1:00 pm – 2:00 pm


Table 1

Rahul Kaushik

Chief Technical Officer
Disc Medicine

What, how, when: navigating CMC considerations for programs on an accelerated approval pathway

2|1|2 - Disc Medicine

Spots Remaining: 0

Alex Witz
89Bio
Dina Chinichian
Gilead Sciences
Heike Abeck
Bayer
John Kumer
Aptevo Therapeutics, LLC
Julie Phillips
BioCardia
Lu Jin
Henlius USA
Marcus Wong
Bluejay Therapeutics
Marty Hughes
Immuneering Corp.
Raedun Clarke
Fate Therapeutics Inc.

TABLE 2

Andy Lin

VP and Global Head, Individualized and Cell Therapy Development, Pharma Technical
Genentech

Enhancing the Development and Manufacturing of Individualized Cell Therapies

2|2|2 - Genentech

Spots Remaining: 0

Andrew Jacobson
BioCardia Inc
Ann Houseman
BMS
Christopher Brown
Seatt
Jianxin Hu
Vor Biopharma
Joe Petrosky
pbs biotech
Kanika Chawla
CARGO Therapeutics
Matthew Tauras
Vor Bio
Rui Tostoes
ImmuneBridge
Stoyana Alexandrova
Novo Nordisk

TABLE 3

Andrew Wirths

SVP, Global Operations
AstraZeneca

Achieving Carbon Zero: AstraZeneca's Path to Sustainability in Manufacturing

2|3|2 - AstraZeneca

Spots Remaining: 0

Bob To
Allogene Therapeutics
Eileen Engelberg
Amgen
Emily Harder
Eli Lilly
Esohe Idusogie
ADC Therapeutics
Keith Kellerman
Vertex Pharmaceuticals
Marjan Javadi
CRISPR
Rajeev Udumula
Genentech
Sarah Blackmore
Sarepta
Terrell Mathews
PBS Biotech

TABLE 4

Christopher Grail

SVP and Head, Global Pharma Engineering
Bayer

Danielle Golay

VP, Biologics and Cell Therapy Quality
Bayer

Synergistic Collaboration Between Production, Engineering and Quality as Important Success Factors In Manufacturing

2|4|2 - Bayer

Spots Remaining: 0

Elisa Ha
ArsenalBio
Irene Xie
Gilead
Lisa Lien
Gilead Sciences, Inc.
Mayank Patel
Sanofi
Mike Ong
Candid Therapeutics
Pallavi Fancy
Pendulum Therapeutics
Richard Truchsess
Boehringer-Ingelheim
Scott Keetch
Bayer

TABLE 5

Suki Toguchi

Chief of Staff
Gilead Sciences

Leading Digital Strategy: Driving Transformation Across Gilead’s Pharma Development and Manufacturing

2|5|2 - Gilead Sciences

Spots Remaining: 0

Betsy Rezner
Fate Therapeutics Inc
Brandon Carr
Astellas Gene Therapies
Harmik Begi
Gilead Sciences
Jason Berndt
Bristol Myers Squibb
Joe Tarantino
Astellas
John Marella
KalVista Pharmaceuticals
Paul Tyson
Boehringer Ingelheim
Rekha Nair
Novo Nordisk
Stan Khoruzhenko
Bayer

TABLE 6

Rakesh Kakkar

VP and Head, Manufacturing and Supply Vaccines, US
Sanofi

Driving Operational excellence, Quality and Compliance in Biomanufacturing

2|6|2 - Sanofi

Spots Remaining: 0

Ayo Balogun
Eikon Therapeutics, Inc
Cindy Chang
Legend Biotech
Cynthia Provencher
KalVista Pharmaceuticals
Drew Johnston
Bayer
Harini Sundar
Gilead Sciences
Michael Deperro
Deperro
Rainer Haemmerle
Boehringer Ingelheim Fremont
Roger Lee
89bio
Vanessa Strings-ufombah
Adverum Biotechologies